Question 1

What are the potential benefits of trying PF-04217329 compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 clinical trial (NCT00934089). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I expect from this new treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 clinical trial (NCT00934089). Contact the study team or your healthcare provider for specific answers.

Question 3

How will my eye pressure be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 clinical trial (NCT00934089). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any risks associated with participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 clinical trial (NCT00934089). Contact the study team or your healthcare provider for specific answers.

Question 5

How does this study fit with my overall treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 clinical trial (NCT00934089). Contact the study team or your healthcare provider for specific answers.

What this study is about